Skip to main content

Edwards Lifesciences Corp

corporate_fare Company Profile

Edwards Lifesciences Corp

EW·NYSE·Industrial Applications And Services·CIK 0001099800

Edwards Lifesciences Corporation is a global structural heart innovation company focused on improving patient lives through medical technologies. The company has been a leader in its field for over six decades, building on its founder's vision to use engineering for heart disease. Edwards Lifesciences develops both surgical and transcatheter therapies. Its portfolio includes repair and replacement technologies for aortic, mitral, tricuspid, and pulmonic heart valves, offering treatment options for diverse and complex patient needs. The company's strategy emphasizes transformative product innovation, high-quality clinical evidence to support approvals and adoption, and comprehensive support for patient outcomes. Cardiovascular disease is the leading cause of death globally and the top disease in healthcare spending in nearly every country. In the U.S., one cardiovascular patient dies every 34 seconds. This disease is progressive and often affects heart structure. Edwards Lifesciences aims to transform patient care through earlier diagnosis, routine treatment, increased longevity, and improved quality of life. Future growth opportunities include solutions for patients with both valvular and non-valvular structural heart disease, such as heart failure, which can result from conditions like aortic stenosis, mitral and tricuspid regurgitation, and aortic regurgitation. The company's medical technologies are designed to address individual patient needs based on disease process, comorbidities, and health status.

Edwards Lifesciences Corp (NYSE:EW) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for EW at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 13 rated 8 or above. Recent SEC coverage for EW spans 8-K, 10-Q, DEF 14A.

Recent high-impact activity:

  • CMS Finalizes TAVR Coverage Rules as Edwards Adds PASCAL Ace, EVOQUE Approvals
  • Edwards Q3 Sales Up 10.5% to $1.72B; Full-Year Guidance Raised Across TAVR, TMTT and EPS
  • Edwards Beats on 11.2% Growth, Raises Full-Year Sales and EPS Guidance
  • PASCAL Beats Medical Therapy in Tricuspid Repair Trial, 80% Cut to Moderate-or-Less TR
  • PROGRESS Trial: TAVR Cuts Death/Heart Failure Risk 33% in Moderate Aortic Stenosis

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$6.07B
Net Income
$1.07B
Diluted EPS
$1.83
Op. Cash Flow
$1.6B
Free Cash Flow
$1.33B
Gross Profit
$4.73B
Operating Income
$1.26B
Cash & Equivalents
$2.94B
Total Debt
$598.3M
Debt / Equity
0.06×
Net Margin
17.7%
Shares Outstanding
580.7M sh
Source: 10-K · filed 2026-02-25 · accession 0001099800-26-000009

Short Interest & Short Volume

2.80 days to cover

FINRA reported short interest of 9,382,239 shares in EW as of the October 30, 2026 settlement, a 0.5% increase from the prior period — about 2.8 days to cover at its recent average daily volume. On November 19, 2026, 31.8% of EW volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)9,382,239 shares as of October 30, 2026
Change vs prior period▲ 0.5%
Days to cover2.80 at avg daily volume of 3,346,352
Daily short volume (FINRA facilities)31.8% of 1,167,511 shares on November 19, 2026
5-day average short volume42.6%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with E →
$103.84 -0.04% today
52-week range · as of 2026-11-04 $74.66 – $103.84
Market cap
$59.73B
Volume
3.7M (0.8× avg)
3-mo avg 4.6M
Live data · 2026-11-20 14:14 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed EW - Latest Insights

EW
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $103.00
Real-time Price: $103.84 info
Change: +$0.840 (+0.82%) info
Market Cap: $59.731B info
EW
Nov 04, 2026, 4:21 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $104.54
Real-time Price: $103.84 info
Change: -$0.700 (-0.67%) info
Market Cap: $59.731B info
EW
Nov 04, 2026, 4:15 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $99.99
Real-time Price: $103.84 info
Change: +$3.85 (+4%) info
Market Cap: $59.731B info
EW
Nov 02, 2026, 1:25 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $90.76
Real-time Price: $103.84 info
Change: +$13.08 (+14%) info
Market Cap: $59.731B info
EW
Nov 02, 2026, 12:40 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $95.17
Real-time Price: $103.84 info
Change: +$8.67 (+9%) info
Market Cap: $59.731B info
EW
Oct 21, 2026, 10:07 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $87.12
Real-time Price: $103.84 info
Change: +$16.72 (+19%) info
Market Cap: $59.731B info
EW
Oct 16, 2026, 11:13 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $86.74
Real-time Price: $103.84 info
Change: +$17.11 (+20%) info
Market Cap: $59.731B info
EW
Oct 15, 2026, 6:36 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $88.25
Real-time Price: $103.84 info
Change: +$15.59 (+18%) info
Market Cap: $59.731B info
EW
Oct 01, 2026, 4:26 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $85.19
Real-time Price: $103.84 info
Change: +$18.65 (+22%) info
Market Cap: $59.731B info
EW
Aug 04, 2026, 4:14 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $90.01
Real-time Price: $103.84 info
Change: +$13.83 (+15%) info
Market Cap: $59.731B info
EW
Jul 23, 2026, 4:29 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $90.00
Real-time Price: $103.84 info
Change: +$13.84 (+15%) info
Market Cap: $59.731B info
EW
Jul 23, 2026, 4:15 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $90.04
Real-time Price: $103.84 info
Change: +$13.80 (+15%) info
Market Cap: $59.731B info
EW
Jul 13, 2026, 1:14 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $91.94
Real-time Price: $103.84 info
Change: +$11.90 (+13%) info
Market Cap: $59.731B info
EW
May 08, 2026, 4:12 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $79.96
Real-time Price: $103.84 info
Change: +$23.88 (+30%) info
Market Cap: $59.731B info
EW
May 06, 2026, 4:12 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $83.62
Real-time Price: $103.84 info
Change: +$20.22 (+24%) info
Market Cap: $59.731B info
EW
May 04, 2026, 4:53 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $83.33
Real-time Price: $103.84 info
Change: +$20.51 (+25%) info
Market Cap: $59.731B info
EW
Apr 23, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $82.25
Real-time Price: $103.84 info
Change: +$21.59 (+26%) info
Market Cap: $59.731B info
EW
Apr 23, 2026, 4:15 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $82.02
Real-time Price: $103.84 info
Change: +$21.82 (+27%) info
Market Cap: $59.731B info
EW
Mar 26, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $82.10
Real-time Price: $103.84 info
Change: +$21.74 (+26%) info
Market Cap: $59.731B info
EW
Feb 10, 2026, 4:22 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $81.44
Real-time Price: $103.84 info
Change: +$22.40 (+28%) info
Market Cap: $59.731B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets